Wolski K - Search Results

1

Randomized controlled trial of Mycobacterium vaccae immunotherapy in non-human immunodeficiency virus-infected ugandan adults with newly diagnosed pulmonary tuberculosis. The Uganda-Case Western Reserve University Research Collaboration.

Johnson JL, Kamya RM, Okwera A, Loughlin AM, Nyole S, Hom DL, Wallis RS, Hirsch CS, Wolski K, Foulds J, Mugerwa RD, Ellner JJ. Johnson JL, et al. Among authors: wolski k. J Infect Dis. 2000 Apr;181(4):1304-12. doi: 10.1086/315393. Epub 2000 Apr 7. J Infect Dis. 2000. PMID: 10753731 Clinical Trial.

2

Risk factors for adverse drug reactions during thiacetazone treatment of pulmonary tuberculosis in human immunodeficiency virus infected adults.

Okwera A, Johnson JL, Vjecha MJ, Wolski K, Whalen CC, Hom D, Huebner R, Mugerwa RD, Ellner JJ. Okwera A, et al. Among authors: wolski k. Int J Tuberc Lung Dis. 1997 Oct;1(5):441-5. Int J Tuberc Lung Dis. 1997. PMID: 9441099 Clinical Trial.

3

Impact of human immunodeficiency virus type-1 infection on the initial bacteriologic and radiographic manifestations of pulmonary tuberculosis in Uganda. Makerere University-Case Western Reserve University Research Collaboration.

Johnson JL, Vjecha MJ, Okwera A, Hatanga E, Byekwaso F, Wolski K, Aisu T, Whalen CC, Huebner R, Mugerwa RD, Ellner JJ. Johnson JL, et al. Among authors: wolski k. Int J Tuberc Lung Dis. 1998 May;2(5):397-404. Int J Tuberc Lung Dis. 1998. PMID: 9613636

4

Induction of the antigen 85 complex of Mycobacterium tuberculosis in sputum: a determinant of outcome in pulmonary tuberculosis treatment.

Wallis RS, Perkins M, Phillips M, Joloba M, Demchuk B, Namale A, Johnson JL, Williams D, Wolski K, Teixeira L, Dietze R, Mugerwa RD, Eisenach K, Ellner JJ. Wallis RS, et al. Among authors: wolski k. J Infect Dis. 1998 Oct;178(4):1115-21. doi: 10.1086/515701. J Infect Dis. 1998. PMID: 9806042

5

Measurement of sputum Mycobacterium tuberculosis messenger RNA as a surrogate for response to chemotherapy.

Desjardin LE, Perkins MD, Wolski K, Haun S, Teixeira L, Chen Y, Johnson JL, Ellner JJ, Dietze R, Bates J, Cave MD, Eisenach KD. Desjardin LE, et al. Among authors: wolski k. Am J Respir Crit Care Med. 1999 Jul;160(1):203-10. doi: 10.1164/ajrccm.160.1.9811006. Am J Respir Crit Care Med. 1999. PMID: 10390401

6

The benefit of abciximab in percutaneous coronary revascularization is not device-specific.

Bhatt DL, Lincoff AM, Califf RM, Simoons ML, Tcheng JE, Brener SJ, Wolski KE, Topol EJ. Bhatt DL, et al. Among authors: wolski ke. Am J Cardiol. 2000 May 1;85(9):1060-4. doi: 10.1016/s0002-9149(00)00696-2. Am J Cardiol. 2000. PMID: 10781752

7

Abciximab reduces mortality in diabetics following percutaneous coronary intervention.

Bhatt DL, Marso SP, Lincoff AM, Wolski KE, Ellis SG, Topol EJ. Bhatt DL, et al. Among authors: wolski ke. J Am Coll Cardiol. 2000 Mar 15;35(4):922-8. doi: 10.1016/s0735-1097(99)00650-6. J Am Coll Cardiol. 2000. PMID: 10732889 Free article.

8

Beta-blockers and progression of coronary atherosclerosis: pooled analysis of 4 intravascular ultrasonography trials.

Sipahi I, Tuzcu EM, Wolski KE, Nicholls SJ, Schoenhagen P, Hu B, Balog C, Shishehbor M, Magyar WA, Crowe TD, Kapadia S, Nissen SE. Sipahi I, et al. Ann Intern Med. 2007 Jul 3;147(1):10-8. doi: 10.7326/0003-4819-147-1-200707030-00003. Ann Intern Med. 2007. PMID: 17606956

9

Defining the optimal activated clotting time during percutaneous coronary intervention: aggregate results from 6 randomized, controlled trials.

Chew DP, Bhatt DL, Lincoff AM, Moliterno DJ, Brener SJ, Wolski KE, Topol EJ. Chew DP, et al. Among authors: wolski ke. Circulation. 2001 Feb 20;103(7):961-6. doi: 10.1161/01.cir.103.7.961. Circulation. 2001. PMID: 11181470

10

Pronounced benefit of coronary stenting and adjunctive platelet glycoprotein IIb/IIIa inhibition in complex atherosclerotic lesions.

Cura FA, Bhatt DL, Lincoff AM, Kapadia SR, L'Allier PL, Ziada KM, Wolski KE, Moliterno DJ, Brener SJ, Ellis SG, Topol EJ. Cura FA, et al. Among authors: wolski ke. Circulation. 2000 Jul 4;102(1):28-34. doi: 10.1161/01.cir.102.1.28. Circulation. 2000. PMID: 10880411 Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

240 results

Search Page

Filters